SCHEMBL19918982

SCHEMBL19918982

COc1cc(C(=O)NC2CCN(C3CCOCC3)CC2)c(C)cc1Nc1ncc(Cl)c(Oc2cccc(CN(C)C)c2C=O)n1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19918907 0.82 PTK2 (0.69) PTK2
SCHEMBL23939895 0.81 PTK2 (0.81) PTK2
SCHEMBL12135497 0.81 PTK2 (1.00) PTK2
SCHEMBL19919015 0.80 PTK2 (0.72) PTK2
SCHEMBL19919100 0.76 PTK2 (0.68) PTK2
SCHEMBL12135042 0.76 PTK2 (1.00) PTK2
SCHEMBL12137088 0.74 PTK2 (0.92) PTK2
SCHEMBL23939940 0.74 PTK2 (0.74) PTK2
SCHEMBL19919109 0.73 PTK2 (0.79) PTK2
SCHEMBL12135475 0.72 PTK2 (1.00) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B9 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER IPHARMA H K LTD (HK) 2021-10-20 — — EP disclosed
EP-2367800-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER BOEHRINGER INGELHEIM INT (DE) 2018-02-28 — — EP disclosed
Send feedback